Heidelberg Pharma AG Sustainability Reports
Heidelberg Pharma AG is a biopharmaceutical company specializing in oncology. It is the first company to develop antibody-targeted amanitin conjugates (ATACs) using its proprietary ADC technology platform.
Sector: Manufacturing
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 391200E09XYBYITR1W32
FIGI: BBG001SDHKN0
7 reports from 2017 to 2025
